Skip to main content
Loading

Prioritizing Alternative Funding Sources

February 11, 2025
As venture capital remains difficult to reach, the availability of debt financing, royalty financing, family office funding, and other alternative methods, as well as PIPEs for public companies, become more attractive options. This panel of expert deal makers will share lessons learned on prioritizing and pursuing alternative funding sources.​
Speakers
Lucas De Breed, Director, Investments - BrightEdge - American Cancer Society
Brienne Kugler, Senior Vice President, Research & Investments - Royalty Pharma
View all 2025 Program
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP